Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-5292

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-5292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5292 9)

Atorvastatin Calcium 20 mg film-coated tablet packaging label from NuCare Pharmaceuticals, Inc. The label states the product contains oval, white, biconvex tablets with 'MA' on one side and '2' on the other. It includes NDC 68071-5292-9 and instructions to keep out of reach of children and store at controlled temperature 68-77°F. This package contains 90 tablets.*

FDA Label Image

Atorvastatin-figure-01 (Atorvastatin Figure 01)

A line chart comparing cumulative incidence percentages over approximately 3.5 years for atorvastatin and placebo groups. The chart shows atorvastatin with a lower cumulative incidence than placebo, with a hazard ratio (HR) of 0.64 and a p-value of 0.0005.*

FDA Label Image

Atorvastatin-figure-02 (Atorvastatin Figure 02)

A line graph showing cumulative hazard (%) over time to first primary endpoint through four years of follow-up. Two lines compare Atorvastatin and Placebo, with Placebo having consistently higher cumulative hazard. The graph includes a hazard ratio (HR) of 0.63 (0.48-0.83) and p-value of 0.001.*

FDA Label Image

Atorvastatin-figure-03 (Atorvastatin Figure 03)

A line chart comparing the percentage of subjects experiencing a major cardiovascular event over 5 years between Atorvastatin 10 mg and Atorvastatin 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis represents the percentage of subjects. The graph includes a hazard ratio (HR) of 0.78 with confidence interval (0.69-0.89) and a p-value of 0.0002.*

FDA Label Image

Structure (Atorvastatin Structure)

Chemical structure of atorvastatin calcium shown as a detailed molecular diagram including its associated calcium ions and water of crystallization (3H2O). The layout illustrates multiple aromatic rings, hydroxyl groups, and carboxyl groups typical of atorvastatin calcium hydrate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.